High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.2M
$2,201,698
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Director
Other
|
2026-03-31 | $5,056 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Soteropoulos Paula
• Director
10b5-1 Sell
2026-03-31
$47,986
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Director
10b5-1 Sell
|
2026-03-31 | $47,986 | S | Form 4 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Director
Other
|
2026-03-24 | $232,893 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Soteropoulos Paula
• Director
10b5-1 Sell
2026-03-24
$2,153,712Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Director
10b5-1 Sell
|
2026-03-24 | $2,153,712Large | S | Form 4 |